USD 5.36 billion
U.S. Intravenous Immunoglobulin Market Size, Share, Growth Analysis, By Application(Primary Immunodeficiency, Chronic Inflammatory, Demyelinating Polyradiculoneuropathy, Congenital AIDS), By Distribution Channels(Hospital Pharmacy, Specialty Pharmacy, others), By Region - Industry Forecast 2024-2031
Report ID:
SQMIC35G2279 |
Region:
Country |
Published Date: March, 2024
Pages:
219
|Tables:
70
|Figures:
77
U.S. Intravenous Immunoglobulin Market Insights
U.S. Intravenous Immunoglobulin Market size was valued at USD 5.78 billion in 2022 and is poised to grow from USD 6.24 billion in 2023 to USD 11.46 billion by 2031, at a CAGR of 7.90% during the forecast period (2024-2031).
The need for immunoglobulin replacement therapy to treat Primary Immunodeficiency Diseases (PIDD) is rising, and this is one of the main drivers of the U.S. IVIG market.
Another key driver is the approval of new medicines, which is expanding the range of available treatments for patients. Adoption of home infusion therapy increased exponentially, which can be linked to the immunocompromised patients' weakened immunity and the safer administration of medications at home. Post-pandemic, the tendency is predicted to persist.
The COVID-19 pandemic has caused significant changes in the industry's market dynamics. Due to the increased demand for plasma products in the early stages of the pandemic for the treatment of SARS-CoV-2 patients, there was a scarcity of immunoglobulin products in the U.S. IVIG market.
The drop in plasma donations during the epidemic compounded this stress by placing a major strain on the plasma supply system. Because plasma fractionations take time, there were supply problems in the beginning of 2021.Businesses are looking into IGIV therapies as a possible kind of treatment.
Higher treatment adoption may result from approval in the following years. Immunoglobulin therapy is costly, which prevents the U.S. from using IVIG more widely. For Instance, according to NCBI, the typical session cost in the U.S. was roughly U.S.D 9,720, which equates to a monthly cost of USD 41,796 for 4.3 sessions.
Patients without insurance or Medicare may find it challenging to receive care because the average annual cost of treating a CIDP patient exceeds USD 136,000. Key manufacturers are putting more emphasis on getting new products approved and into the market in order to meet the growing demand from patients for IVIG due to the evolving needs of the patient population. Multiple autoimmune, neurological, haematological, and immunodeficiency illnesses are all treated with IVIG replacement therapy.
US Intravenous Immunoglobulin Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Network
Fastest Growth
Network
Growth Rate
7.9% CAGR
US Intravenous Immunoglobulin Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
U.S. Intravenous Immunoglobulin Market Segmental Analysis
The U.S. intravenous immunoglobulin market is segmented on the basis of application, distribution channels and region. By application, the market is segmented into primary immunodeficiency, chronic inflammatory, demyelinating polyradiculoneuropathy, congenital aids, chronic lymphocytic leukemia, myasthenia gravis, multifocal motor neuropathy, immune thrombocytopenia, kawasaki disease, guillain-barre syndrome. By distribution channels, market is segmented into hospital pharmacy, specialty pharmacy, others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
U.S. Intravenous Immunoglobulin Market Analysis by Distribution Channels
Due to the high number of hospitals and the simple accessibility of goods inside the hospitals, the hospital pharmacies sector had the greatest revenue share of the U.S. IVIG market in 2022, accounting for 57.46% of total sales. The simple accessibility of goods in hospitals has fueled the development of this market. Additionally, compared to conventional retail pharmacies, hospital-owned outpatient pharmacies have an advantage because they have access to a patient's electronic health information. As a result, patients are able to get the necessary prescriptions without a prescription from a physician. These elements can be linked to the expansion of this market category.
it is predicted that the specialized pharmacy segment would experience significant expansion. Because specialty pharmacies make it simple to receive treatment at home, this market segment is expected to grow significantly during the projected period. The future of the pharmacy industry will include a sizable and growing portion of specialty medications. According to CVS statistics from May 2021, specialty medications made up 52% of total pharmacy spending in 2020. Additionally, the number of novel treatments for related illnesses has increased by 98%.
U.S. Intravenous Immunoglobulin Market Analysis by Application
Due to the high cost of treatment and the increasing number of patients needing treatment, the primary immunodeficiency diseases sector held the biggest market share of the U.S. IVIG market in 2022, accounting for 21.32% of the total. There have been approximately 300 different forms of PIDDs reported, according to the American Academy of Allergy, Asthma, & Immunology. There are approximately 270,000 cases of PIDD in the United States, or 1 in 1,200. It is expected that the presence of organizations like the Immune Deficiency Foundation, which seek to enhance PIDD diagnosis and treatment through lobbying, education, and research, will increase patient adoption of IVIG therapy.
The IVIG treatment is effective in 85% of CIPD patients, which is anticipated to promote its acceptance, and CIDP is predicted to rise at the fastest rate. Major players are concentrating on creating cutting-edge formulations for the prevention and treatment of CIPD. For instance, Takeda published positive findings from the Phase 3 clinical study for HYQVIA in July 2022, which is approved for the treatment and maintenance of CIPD. In 2022, the company submitted regulatory applications in the U.S. and Europe.
US Intravenous Immunoglobulin Market Size By Type (%)
To get detailed analysis on other segments, Request For Free Sample Report
U.S. Intravenous Immunoglobulin Market Regional Insights
The Northeast region, comprising states such as New York, New Jersey, Massachusetts, Pennsylvania, and Connecticut, has a significant presence in the IVIG market. This region is home to renowned medical institutions, research facilities, and academic centers, which contribute to the availability and adoption of IVIG treatments. The dense population and advanced healthcare infrastructure in cities like New York City and Boston further enhance the prominence of the IVIG market in the Northeast.
The Mid-Atlantic region, including states such as Pennsylvania, Maryland, Virginia, and Delaware, is another important market for IVIG in the US. This region is known for its strong healthcare systems, with major cities like Philadelphia and Baltimore hosting renowned medical institutions. The presence of leading hospitals and healthcare providers contributes to the availability and utilization of IVIG therapies in the Mid-Atlantic region.
US Intravenous Immunoglobulin Market Size By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
U.S. Intravenous Immunoglobulin Market Dynamics
U.S. Intravenous Immunoglobulin Market Drivers
Innovation and Product Variety
- Frozen dessert manufacturers continue to innovate and introduce new flavors, textures, and formats to cater to evolving consumer preferences. This includes offering healthier options, such as low-fat, low-sugar, and dairy-free alternatives, to meet the growing demand for healthier treats.
Premiumization and Artisanal Offerings
- There is a rising trend toward premium and artisanal frozen desserts in the U.S. market. Consumers are willing to pay more for higher-quality products made with premium ingredients and unique flavour combinations. This has led to the growth of small-batch producers and artisanal ice cream shops.
U.S. Intravenous Immunoglobulin Market Restraints
Volatile Ingredient Costs
- The cost of ingredients used in frozen desserts, such as dairy products, fruits, and flavourings, can be subject to significant fluctuations. Fluctuating ingredient costs can impact profit margins for manufacturers, especially smaller producers who may not have the same purchasing power as larger companies. Managing these cost fluctuations while maintaining product quality and pricing can be a challenge.
Request Free Customization of this report to help us to meet your business objectives.
U.S. Intravenous Immunoglobulin Market Competitive Landscape
The top companies in the IVIG market in the US are concentrating on growth tactics such as product releases, R&D, mergers & acquisitions, and advancements in the IVIG products already on the market.
U.S. Intravenous Immunoglobulin Market Top Player’s Company Profiles
- Nestlé (Switzerland)
- Unilever (Netherlands/UK)
- General Mills (United States)
- The Kraft Heinz Company (United States)
- Mars, Incorporated (United States)
- Blue Bell Creameries (United States)
- Wells Enterprises, Inc. (United States)
- Dreyer's Grand Ice Cream Holdings, Inc. (United States)
- Rich Products Corporation (United States)
- Ben & Jerry's Homemade Holdings Inc. (United States)
- Häagen-Dazs (United States)
- Turkey Hill Dairy (United States)
- Tillamook County Creamery Association (United States)
- Dean Foods (United States)
- Breyers (United States)
- TCBY (United States)
- Velvet Ice Cream (United States)
- Good Humor (United States)
- Jeni's Splendid Ice Creams (United States)
- Perry's Ice Cream (United States)
- Talenti Gelato (United States)
- Coolhaus (United States)
U.S. Intravenous Immunoglobulin Market Recent Developments
- In March 2023, the FDA approved a new indication for SCIG (subcutaneous IVIG) for the treatment of primary immunodeficiency diseases. This approval makes SCIG an available treatment option for patients who are unable to receive IVIG infusions.
U.S. Intravenous Immunoglobulin Key Market Trends
- Indulgent and Decadent Treats : Despite the growing emphasis on healthier options, indulgence remains a strong driver in the frozen dessert market. Consumers still seek rich, creamy, and indulgent frozen treats like premium ice creams, gelatos, and decadent frozen novelties. Manufacturers continue to offer luxurious Flavors and textures to satisfy these cravings.
U.S. Intravenous Immunoglobulin Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analyses, the US frozen dessert market is significant in size and continues to grow steadily. Factors such as consumer demand, innovation, and product variety contribute to its growth. While specific market figures may vary, the market was valued at several billion dollars in recent years, with projections of continued growth. Manufacturers continuously introduce new Flavors, textures, and formats to cater to evolving consumer preferences, including healthier options and premium offerings. The US frozen dessert market presents opportunities for growth and innovation. Consumer demand, evolving preferences, and the focus on health and wellness shape the market landscape. Manufacturers need to stay adaptable, invest in research and development, and cater to changing consumer demands to remain competitive in this dynamic industry.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 5.78 billion |
| Market size value in 2031 | USD 11.46 billion |
| Growth Rate | 7.90% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on U.S. Intravenous Immunoglobulin Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on U.S. Intravenous Immunoglobulin Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the U.S. Intravenous Immunoglobulin Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the U.S. Intravenous Immunoglobulin Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the U.S. Intravenous Immunoglobulin Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the U.S. Intravenous Immunoglobulin Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
